Oxford Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Oxford Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-35,809	Closed	-$3.74M	–	1626
2019 Q4	$3.74M	Buy	+35,809	New	+$4.02M	0.1%	206
2019 Q1	–	Sell	-7,713	Closed	-$751K	–	2125
2018 Q4	$751K	Buy	+7,713	New	+$1.01M	0.02%	997
2018 Q3	–	Sell	-2,270	Closed	-$314K	–	2039
2018 Q2	$314K	Sell	2,270 -9,970	-81%	-$1.42M	0.01%	1489
2018 Q1	$1.38M	Buy	+12,240	New	+$1.54M	0.03%	777

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Oxford Asset Management's GWPH Position: Q1 2020 in Review

Oxford Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 35,809 shares — an estimated $3.74M sold.

Oxford Asset Management first reported a position in GWPH in Q1 2018 and held it in 4 quarters. The position peaked at $3.74M in Q4 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Oxford Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 35,809 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $3.74M.
Oxford Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 4 quarters.
Oxford Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.74M in Q4 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.